These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 4144869

  • 1. The neuromuscular and other blocking actions of 4,17a-dimethyl-4,17a-diaza-D-homo-5 -androstane dimethiodide.
    Marshall IG, Singh H, Paul D.
    J Pharm Pharmacol; 1972 Dec; 24():Suppl:146P. PubMed ID: 4144869
    [No Abstract] [Full Text] [Related]

  • 2. Some actions of 4,17a-dimethyl-4,17a-diaza-D-homo-5alpha-androstane dimethiodide (HS-342), a new neuromuscular blocking drug.
    Marshall IG, Paul D, Singh H.
    J Pharm Pharmacol; 1973 Jun; 25(6):441-6. PubMed ID: 4146581
    [No Abstract] [Full Text] [Related]

  • 3. The neuromuscular and other blocking actions of 4,17a-dimethyl-4,17a-diaza-d-homo-5 -androstane dimethiodide (HS-342) in the anaesthetized cat.
    Marshall IG, Paul D, Singh H.
    Eur J Pharmacol; 1973 May; 22(2):129-34. PubMed ID: 4715215
    [No Abstract] [Full Text] [Related]

  • 4. Neuromuscular and other blocking actions of a new series of mono and bisquaternary aza steroids.
    Gandiha A, Marshall IG, Paul D, Singh H.
    J Pharm Pharmacol; 1974 Nov; 26(11):871-7. PubMed ID: 4156557
    [No Abstract] [Full Text] [Related]

  • 5. Quillaiate of choline iodide: a new monoquaternary neuromuscular blocking agent.
    Hamed MI, el-Gholmy Z.
    Arzneimittelforschung; 1972 Dec; 22(12):2133-6. PubMed ID: 4350747
    [No Abstract] [Full Text] [Related]

  • 6. [Blocking of the neuromuscular conduction by decamethylene-bis-pyridinium].
    Danilov AF.
    Farmakol Toksikol; 1970 Dec; 33(5):536-8. PubMed ID: 4250151
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of new neuromuscular blocking agents.
    Karis JH, Gissen AJ.
    Anesthesiology; 1971 Aug; 35(2):149-57. PubMed ID: 4327948
    [No Abstract] [Full Text] [Related]

  • 12. The muscle relaxants and their antagonists.
    Stovner J, Lund I.
    Br J Anaesth; 1970 Mar; 42(3):235-48. PubMed ID: 4193499
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Mechanism of hypotensive effects of verticillatine].
    Tian BH, Zeng GY.
    Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):58-63. PubMed ID: 2903612
    [No Abstract] [Full Text] [Related]

  • 15. Formulation of d-tubocurarine.
    Clarke RS, Lyons SM.
    Anesthesiology; 1971 Oct; 35(4):441. PubMed ID: 4107153
    [No Abstract] [Full Text] [Related]

  • 16. [Neuromuscular effects of vecuronium d-tubocurarine and succinylcholine in malnourished rat's diaphragm].
    Tajiri O.
    Masui; 1996 May; 45(5):586-92. PubMed ID: 8847785
    [Abstract] [Full Text] [Related]

  • 17. NON-DEPOLARISING NEUROMUSCULAR BLOCKADE BY 3-ALPHA,17-ALPHA-BIS(QUATERNARY AMMONIUM) 5-ALPHA-ANDROSTANES.
    ALAUDDIN M, CADDY B, LEWIS JJ, MARTIN-SMITH M, SUGRUE MF.
    J Pharm Pharmacol; 1965 Jan; 17():55-8. PubMed ID: 14285698
    [No Abstract] [Full Text] [Related]

  • 18. The pharmacology of a new short-acting, non-depolarising muscle relaxant steroid (RGH-4201).
    Biró K, Kárpáti E.
    Arzneimittelforschung; 1981 Jan; 31(11):1918-24. PubMed ID: 6172135
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Different potency of pancuronium bromide on two types of skeletal muscle.
    Bonta IL, Goorissen EM.
    Eur J Pharmacol; 1968 Oct; 4(3):303-8. PubMed ID: 5723424
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.